-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Misetionamide in Metastatic Adenocarcinoma of The Pancreas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Misetionamide in Metastatic Adenocarcinoma of The Pancreas report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Misetionamide in Metastatic Adenocarcinoma of The Pancreas Drug...
-
Product Insights
NewCardiac Valve Repair Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Valve Repair Devices Pipeline Market Report Overview Cardiac valve repair devices are used in Open-Heart surgery to repair the malfunctioning of valves. Only mitral valve repair has been covered under this segment. Annuloplasty is a technique used to repair an enlarged annulus. This annuloplasty device makes the opening of the valve smaller and provides support to the valve so it can close more tightly. One unit refers to One cardiac valve repair device. The Cardiac Valve Repair Devices pipeline...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lefamulin Acetate in Cystic Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lefamulin Acetate in Cystic Fibrosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lefamulin Acetate in Cystic Fibrosis Drug Details: Lefamulin Acetate or...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lefamulin Acetate in Complicated Skin And Skin Structure Infections (cSSSI)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lefamulin Acetate in Complicated Skin And Skin Structure Infections (cSSSI) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lefamulin Acetate in Complicated Skin...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BC-7013 in Skin And Skin Structure Infections (SSSI)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BC-7013 in Skin And Skin Structure Infections (SSSI) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BC-7013 in Skin And Skin Structure Infections...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Orziloben in Liver Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Orziloben in Liver Diseases report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Orziloben in Liver Diseases Drug Details: Orziloben is under development for...
-
Product Insights
NewNet Present Value Model: Structure Therapeutics Inc’s GSBR-1290
Empower your strategies with our Net Present Value Model: Structure Therapeutics Inc's GSBR-1290 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Equecabtagene Autoleucel in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Equecabtagene Autoleucel in Relapsed Multiple Myeloma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Equecabtagene Autoleucel in Relapsed Multiple Myeloma Drug Details: Equecabtagene...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Equecabtagene Autoleucel in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Equecabtagene Autoleucel in Refractory Multiple Myeloma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Equecabtagene Autoleucel in Refractory Multiple Myeloma Drug Details: Equecabtagene...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – R-327 in Influenza A Virus, H1N1 Subtype Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - R-327 in Influenza A Virus, H1N1 Subtype Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. R-327 in Influenza A Virus, H1N1 Subtype...